OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6133-6145
Open Access | Times Cited: 11

Showing 11 citing articles:

Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Lingxi Wei, Wenqi Yan, Wahid Shah, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35836-e35836
Open Access | Times Cited: 7

Harnessing sulfur-doped carbon nanodots conjugated with IDO inhibitors act as a dual-mode breast cancer immunotherapy
Roberta Cillari, Rita C. Acúrcio, Andreia Barateiro, et al.
Journal of Controlled Release (2025)
Closed Access

Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD)
Susie Lee, Eung-Won Kim, Haeri Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 847-847
Open Access

Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
Pengbo Yang, Junhua Zhang
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1988-1988
Open Access | Times Cited: 9

Skin Cancer Microenvironment: What We Can Learn from Skin Aging?
Andrea D’Arino, Silvia Caputo, Laura Eibenschutz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14043-14043
Open Access | Times Cited: 7

Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma
Kai Hou, Xiaohui Xu, Xin Ge, et al.
BioFactors (2023) Vol. 50, Iss. 2, pp. 250-265
Closed Access | Times Cited: 5

The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells
Maryam Soltani-asl, Parviz Azimnasab-sorkhabi, Túlio Teruo Yoshinaga, et al.
Immunologic Research (2023) Vol. 72, Iss. 3, pp. 430-437
Open Access | Times Cited: 4

Landscape of unconventional γδ T cell subsets in cancer
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Mohammad Soleiman Ekhtiyari, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1

Non-targeted metabolomics analysis of indoleamine 2,3-dioxygenase inhibitor treatment in a mouse model of early-stage lung adenocarcinoma
Meixiang Xu, Jia-Yang Chen, Chaoyang Peng, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 900-915
Open Access

Conventional T Cell Subsets and Their Roles Within the Tumor Microenvironment
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Ephraim Ansa-Addo, et al.
Interdisciplinary cancer research (2024)
Closed Access

Developing reliable classification of dual IDO1/TDO inhibitors using data fusion and majority voting
Zahra Ghaemi, M. Asadollahi-Baboli
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-9
Closed Access

Page 1

Scroll to top